Showing 771-780 of 1043 results for "".
Early Clinically Unsuspected Alzheimer’s Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/early-clinically-unsuspectedalzheimers-disease/31566/Biomarkers can be important tools for diagnosis.Movement Disorders Moment: Rapid Eye Movement Sleep Behavior Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-rapid-eye-movement-sleep-behavior-disorder/30117/This sleep disorder is a strong predictor for the development of synucleinopathies, including Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies.Hometown Highlights: Introducing Hometown Highlights
https://practicalneurology.com/columns/practice-management/hometown-highlights-introducing-hometown-highlights/30172/In this new column, we feature content from presenters at the 2018-2019 Philadelphia Neurological Society meetings.Anti-Alpha-Synuclein Therapies in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/anti-alpha-synuclein-therapies-in-parkinsons-disease/30196/Could therapies developed to stop cancers be the next breakthrough for neurodegenerative disorders?Multiple Sclerosis—The Truth Lies Within Us
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosisthe-truth-lies-within-us/30300/Data presented at the recent ECTRIMS offer fresh insight and potentially new direction into the cause of multiple sclerosis.MRI Volumetrics and CTE: A New Step Toward Detection?
https://practicalneurology.com/diseases-diagnoses/imaging-testing/mri-volumetrics-and-cte-a-new-step-toward-detection/30340/Preliminary findings suggest potential for structural MRI to detect patterns of volume loss in CTE.Pathway to Success? MS Drug Takes Nrf-2 Pathway for Treatment
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pathway-to-success-ms-drug-takes-nrf-2-pathway-for-treatment/30774/BG-12 is an oral therapy under regulatory review in the US and Europe for the treatment of MS.Clinical Focus: Laboratory Testing for Cryptogenic Polyneuropathy
https://practicalneurology.com/columns/practice-management/clinical-focus-laboratory-testing-for-cryptogenic-polyneuropathy/30841/Although available tests have limitations, they may provide important diagnostic clues.The Immune Stroke Spectrum: Navigating Inflammatory Cerebrovascular Disorders
https://practicalneurology.com/diseases-diagnoses/stroke/the-immune-stroke-spectrum-navigating-inflammatory-cerebrovascular-disorders/49163/This review provides a concise overview of commonly encountered inflammatory cerebrovascular disorders, highlighting their clinical features, diagnostic challenges, and treatment strategies, and emphasizing that despite their complexity, early recognition and systematic management often lead to fBlood Pressure Targets After Stroke: How Low Is Too Low?
https://practicalneurology.com/diseases-diagnoses/stroke/blood-pressure-targets-after-stroke-how-low-is-too-low/49161/Acute hypertensive response management after stroke is a dynamic process that requires careful integration of clinical trial evidence, pathophysiologic principles, imaging findings, and patient-specific factors.